Status:
COMPLETED
New Technologies to Determine Carotid Plaque Vulnerability
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
GE Healthcare
Conditions:
Atherosclerosis
Carotid Artery Plaque
Eligibility:
All Genders
18-90 years
Brief Summary
Hypothesis: Identification of vulnerable atherosclerotic plaques (with or without neovascularization) using carotid CEUS is an independent predictor of MACE (over clinical risk factors, stress echo wa...
Detailed Description
This is a prospective cohort study. - Participating Site(s) (principal investigators in parentheses) that will be enrolling patients will be: Mayo Clinic Rochester site (PI: Sharon Mulvagh, MD). Only ...
Eligibility Criteria
Inclusion
- Study eligibility criteria: age ≥ 18 years, suspected or known to have CAD and referred to stress echo lab.
Exclusion
- Previous carotid surgery or angioplasty; Stroke, cardiogenic shock, pulmonary hypertension, heart failure; other serious disease; Prior contraindication to contrast agent.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT02224339
Start Date
September 1 2014
End Date
January 1 2019
Last Update
March 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55902